Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV at an enterprise value of 190 million euros. The company’s wholly-owned subsidiary ...

Created and written by Kay, “The Case” stars Jakob Oftebro and Peter Andersson (pictured above) as a father-son detective duo who must come together to catch a serial killer. The five-episode series ...

Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV at an enterprise value of 190 million euros. The company's wholly-owned subsidiary ...

Global pharma major Lupin Limited (Lupin), announced its wholly owned subsidiary, Nanomi B.V. (Nanomi), has signed a definitive agreement for the acquisition of VISUfarma B.V. (VISUfarma), a portfolio ...

Mumbai-based pharmaceutical major Lupin will acquire Netherlands-based VISUfarma B.V. for an enterprise value of EUR 190 million (about Rs 2,000 crore) through its wholly owned subsidiary Nanomi B.V., ...

While Indian markets opened on a slightly positive note Wednesday, Lupin Ltd stock led the Nifty Midcap 150 losers, trading at Rs 2,027.30, a 1.19% drop from the previous close. Ola Electric and Tube ...

London, Mumbai, 29 September, 2025: Global Healthcare Opportunities, or GHO Capital Partners LLP ("GHO”), the European specialist investor in global healthcare, is delighted to announce the sale of ...

Lupin writer George Kay is writing The Case, a Swedish crime drama, for Netflix. The five-episode series will star Jakob Oftebro and Peter Andersson as lead investigator Thomas and ex-detective Alfred ...

Pharma major Lupin Ltd on Wednesday announced that it has received tentative approval from the US Food and Drug Administration (USFDA) to market its generic version of Bictegravir, Emtricitabine, and ...

Shares of Lupin Ltd dipped 0.81% on Wednesday, September 17, at 11:02 am, after the company said the US Food and Drug Administration (USFDA) issued six observations for its Nagpur injectable facility.

Lupin shares dropped 1.1% following USFDA inspection USFDA issued six observations at Nagpur injectable facility Company committed to addressing observations within deadline Lupin shares declined ...